DXPE vs. ETON
DXPE (DXP Enterprises, Inc.) and ETON (Eton Pharmaceuticals Inc) are both stocks. DXPE operates in Industrial Distribution (Industrials), while ETON operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, DXPE returned 39.05%/yr vs 36.00%/yr for ETON. At a 0.19 correlation, their price movements are largely independent.
Performance
DXPE vs. ETON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXPE achieves a 53.85% return, which is significantly lower than ETON's 86.81% return.
DXPE
- 1D
- 0.88%
- 1M
- 15.49%
- YTD
- 53.85%
- 6M
- 54.45%
- 1Y
- 114.27%
- 3Y*
- 67.49%
- 5Y*
- 39.05%
- 10Y*
- 27.71%
ETON
- 1D
- -1.62%
- 1M
- 2.50%
- YTD
- 86.81%
- 6M
- 89.16%
- 1Y
- 117.71%
- 3Y*
- 102.22%
- 5Y*
- 36.00%
- 10Y*
- —
DXPE vs. ETON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
DXPE DXP Enterprises, Inc. | 53.85% | 32.89% | 145.16% | 22.32% | 7.32% | 15.47% | -44.16% | 43.00% | -29.91% |
ETON Eton Pharmaceuticals Inc | 86.81% | 26.95% | 204.11% | 55.32% | -34.27% | -47.23% | 12.92% | 17.65% | -4.23% |
Correlation
The correlation between DXPE and ETON is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Nov 13, 2018 | 0.19 |
Fundamentals
DXPE:
$2.77B
ETON:
$996.57M
DXPE:
$5.35
ETON:
-$0.05
DXPE:
1.35
ETON:
10.20
DXPE:
5.40
ETON:
32.55
DXPE:
$2.06B
ETON:
$86.93M
DXPE:
$654.27M
ETON:
$47.61M
DXPE:
$210.11M
ETON:
$5.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXPE vs. ETON — Risk / Return Rank
DXPE
ETON
DXPE vs. ETON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DXP Enterprises, Inc. (DXPE) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXPE | ETON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | -0.44 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.36 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.48 | 3.27 | +0.21 |
| Martin ratioReturn relative to average drawdown | 9.64 | 6.73 | +2.90 |
Loading charts...
Drawdowns
DXPE vs. ETON - Drawdown Comparison
The maximum DXPE drawdown since its inception was -95.45%, which is greater than ETON's maximum drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for DXPE and ETON.
Loading charts...
Drawdown Indicators
| DXPE | ETON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.45% | -79.94% | -15.51% |
Max Drawdown (1Y)Largest decline over 1 year | -32.99% | -36.17% | +3.18% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -45.65% | +12.66% |
Max Drawdown (5Y)Largest decline over 5 years | -37.98% | -70.42% | +32.44% |
Max Drawdown (10Y)Largest decline over 10 years | -77.28% | — | — |
Current DrawdownCurrent decline from peak | -6.94% | -9.74% | +2.80% |
Average DrawdownAverage peak-to-trough decline | -54.49% | -37.58% | -16.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.90% | 17.56% | -5.66% |
Volatility
DXPE vs. ETON - Volatility Comparison
The current volatility for DXP Enterprises, Inc. (DXPE) is 12.93%, while Eton Pharmaceuticals Inc (ETON) has a volatility of 17.63%. This indicates that DXPE experiences smaller price fluctuations and is considered to be less risky than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXPE | ETON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.93% | 17.63% | -4.70% |
Volatility (6M)Calculated over the trailing 6-month period | 35.29% | 40.49% | -5.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.74% | 54.85% | -3.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.37% | 63.41% | -18.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 56.01% | 63.87% | -7.86% |
Dividends
DXPE vs. ETON - Dividend Comparison
Neither DXPE nor ETON has paid dividends to shareholders.
Financials
DXPE vs. ETON - Financials Comparison
This section allows you to compare key financial metrics between DXP Enterprises, Inc. and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXPE vs. ETON - Profitability Comparison
DXPE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DXP Enterprises, Inc. reported a gross profit of 168.61M and revenue of 521.66M. Therefore, the gross margin over that period was 32.3%.
ETON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a gross profit of 14.74M and revenue of 24.27M. Therefore, the gross margin over that period was 60.7%.
DXPE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DXP Enterprises, Inc. reported an operating income of 42.47M and revenue of 521.66M, resulting in an operating margin of 8.1%.
ETON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported an operating income of 2.41M and revenue of 24.27M, resulting in an operating margin of 10.0%.
DXPE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DXP Enterprises, Inc. reported a net income of 19.96M and revenue of 521.66M, resulting in a net margin of 3.8%.
ETON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eton Pharmaceuticals Inc reported a net income of 1.55M and revenue of 24.27M, resulting in a net margin of 6.4%.
Frequently Asked Questions
DXPE and ETON have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ETON has higher volatility (17.63%) compared to DXPE (12.93%). In terms of maximum drawdown, DXPE dropped -95.45% vs ETON's -79.94%.
DXPE currently has the higher Sharpe Ratio (2.22 vs 2.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXPE and ETON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer